BioSpace News Archive

Nimbus Therapeutics today announced positive topline results from a Phase 2b clinical trial evaluating the allosteric TYK2 inhibitor NDI-034858 in patients with moderate-to-severe plaque psoriasis.

Viseon Inc. Announces Preliminary Results of Surgeon Experience Database Utilizing MaxView ® System During Minimally Invasive Lateral Spine Surgery.

The University of Aizu collaborated on development of the technology designed to help verify individuals’ identity and protect data integrity.

Eli Lilly and Company (NYSE: LLY) and Akouos, Inc. (NASDAQ: AKUS) today announced that the tender offer to purchase all of the issued and outstanding shares (“Shares”) of Akouos’s common stock in exchange for (a) $12.50 per Share.

Amryt announces an update regarding the patents for its product Mycapssa® (octreotide).

AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that based on the Phase 1b/2a interim data, ACI-35.030, a potential first-in-class anti-phosphorylated-Tau (pTau) vaccine candidate, has been selected for further development.

Eliem Therapeutics, Inc. today announced that Bob Azelby, Eliem’s president and chief executive officer, will present at the 5th Annual Evercore ISI HealthCONx Virtual Conference being held virtually on Thursday, December 1, 2022 at 11:40 AM ET.

First Wave BioPharma, Inc. announced today that it has submitted an Investigational New Drug (IND) application seeking authorization from the U.S. Food and Drug Administration (FDA) to evaluate an enhanced enteric microgranule delivery formulation of adrulipase as a treatment for exocrine pancreatic insufficiency (EPI) associated with cystic fibrosis (CF) and chronic pancreatitis (CP) in human clinical trials.

Optinose today provided corporate updates and announced that CEO Peter Miller will participate in a fireside chat at the 34th Annual Piper Sandler Healthcare Conference on December 1, 2022.

Iovance Biotherapeutics, Inc. today announced that senior leadership plans to present at the following conferences: Piper Sandler 34th Annual Healthcare Conference Fireside Chat: November 30, 2022 at 10:30 a.m. ET / 7:30 a.m. PT.